EssilorLuxottica S.A. (ESLOY) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Paris, France. The current CEO is Francesco Milleri.
ESLOY has IPO date of 2008-01-30, 153,498 full-time employees, listed on the Other OTC, a market capitalization of $111.1B.
EssilorLuxottica S.A. is a global leader in ophthalmic products, designing, manufacturing, and distributing eyewear across six continents. The company operates through five business segments: Wholesale and Retail (luxury and sports eyewear brands), Lenses and Optical Instruments (including premium lens technologies such as Varilux, Crizal, Transitions, and Eyezen), Equipment (digital surfacing and coating machines), and Sunglasses and Readers (non-prescription eyewear under brands like Foster Grant and licensed labels). With a network of 490 prescription laboratories and edging-mounting facilities worldwide, EssilorLuxottica serves opticians, eye care professionals, and consumers through both wholesale and direct retail channels. The company was formed through the 2018 merger of Essilor International and Luxottica.
